[The use of B.I. 1070/P (guacetisal) in inflammatory bronchopneumopathies in the acute phase].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D001241:Aspirin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001769:Blood / Q000187:drug effects; D001991:Bronchitis / Q000188:drug therapy*; D001996:Bronchopneumonia / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003371:Cough / Q000188:drug therapy; D004417:Dyspnea / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012119:Respiration / Q000187:drug effects
D001241:Aspirin; C023557:guacetisal
Impiego del B.I. 1070/P (guacetisal) nelle broncopneumopatie flogistiche in fase acuta.